Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

A multi-stakeholder perspective on medical devices for children and adolescents with type 1 diabetes: huge unmet needs for the smallest.

PMID: 40965839 · 2025

JournalJournal of pediatric endocrinology & metabolism : JPEM
Year2025
PMID40965839

Abstract

Medical devices for glycaemic control have revolutionised the lives of people with type 1 diabetes (TD1), yet providing children and adolescents with T1D with suitable automated insulin delivery (AID) systems remains challenging, leading to unmet medical needs. The conect4children network organised an international multi-stakeholder meeting in conjunction with the Advanced Technologies and Treatment in Diabetes (ATTD) 2023 congress to discuss how to improve access to suitable AID systems for you

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.